nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—Betaxolol—glaucoma	0.0576	0.386	CbGbCtD
Alitretinoin—ABCB1—Timolol—glaucoma	0.0324	0.218	CbGbCtD
Alitretinoin—CYP1A2—Clonidine—glaucoma	0.0315	0.212	CbGbCtD
Alitretinoin—ABCB1—Clonidine—glaucoma	0.0276	0.185	CbGbCtD
Alitretinoin—CRABP1—eye—glaucoma	0.00271	0.144	CbGeAlD
Alitretinoin—CRABP1—retina—glaucoma	0.00268	0.143	CbGeAlD
Alitretinoin—CRABP1—connective tissue—glaucoma	0.00261	0.139	CbGeAlD
Alitretinoin—CRABP2—eye—glaucoma	0.00245	0.13	CbGeAlD
Alitretinoin—CRABP2—connective tissue—glaucoma	0.00236	0.125	CbGeAlD
Alitretinoin—RXRG—eye—glaucoma	0.00214	0.114	CbGeAlD
Alitretinoin—RARG—eye—glaucoma	0.00179	0.0949	CbGeAlD
Alitretinoin—RARG—retina—glaucoma	0.00177	0.094	CbGeAlD
Alitretinoin—CRABP1—Metabolism—CA5A—glaucoma	0.001	0.00743	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000971	0.0072	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000953	0.00706	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000913	0.00677	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000913	0.00677	CbGpPWpGaD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR3C1—glaucoma	0.000873	0.00647	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000869	0.00644	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—NR3C1—glaucoma	0.000854	0.00633	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—IL1A—glaucoma	0.000811	0.00601	CbGpPWpGaD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000801	0.00594	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000779	0.00577	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC6A13—glaucoma	0.000775	0.00575	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000747	0.00554	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000675	0.005	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.00067	0.00496	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000655	0.00485	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—NR3C1—glaucoma	0.000652	0.00483	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00065	0.00481	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TXN—glaucoma	0.000637	0.00472	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—NR3C1—glaucoma	0.000635	0.00471	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—FAS—glaucoma	0.000631	0.00468	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—NR3C1—glaucoma	0.000613	0.00454	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—FAS—glaucoma	0.000594	0.0044	CbGpPWpGaD
Alitretinoin—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000592	0.00439	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000581	0.0043	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC6A1—glaucoma	0.000568	0.00421	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000557	0.00413	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000555	0.00411	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PEX19—glaucoma	0.000551	0.00408	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000544	0.00403	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000535	0.00397	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000535	0.00397	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000532	0.00394	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000513	0.0038	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00051	0.00378	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000504	0.00374	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—ABCA1—glaucoma	0.000493	0.00366	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CA1—glaucoma	0.00049	0.00363	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CA1—glaucoma	0.00049	0.00363	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000483	0.00358	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—glaucoma	0.000476	0.00353	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CTSA—glaucoma	0.000474	0.00351	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CTSA—glaucoma	0.000474	0.00351	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB2—glaucoma	0.000463	0.00343	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000457	0.00339	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000455	0.00337	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CA2—glaucoma	0.000448	0.00332	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CA2—glaucoma	0.000448	0.00332	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000438	0.00324	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000438	0.00324	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000438	0.00324	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000438	0.00324	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000436	0.00323	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GSTT1—glaucoma	0.000433	0.00321	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000403	0.00298	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000389	0.00288	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000389	0.00288	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000373	0.00277	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000372	0.00276	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.00037	0.00274	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—CYP1B1—glaucoma	0.000345	0.00256	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000333	0.00247	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000322	0.00239	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—NR3C1—glaucoma	0.000319	0.00237	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000316	0.00234	CbGpPWpGaD
Alitretinoin—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000316	0.00234	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000316	0.00234	CbGpPWpGaD
Alitretinoin—ABCB1—retina—glaucoma	0.000316	0.0168	CbGeAlD
Alitretinoin—CRABP1—Metabolism—TXN—glaucoma	0.000316	0.00234	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—TXN—glaucoma	0.000316	0.00234	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GSTM1—glaucoma	0.000314	0.00233	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—FAS—glaucoma	0.000309	0.00229	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CA5A—glaucoma	0.000304	0.00225	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NARFL—glaucoma	0.000304	0.00225	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000301	0.00223	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000296	0.0022	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000296	0.00219	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00029	0.00215	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000288	0.00213	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000288	0.00213	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000286	0.00212	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000285	0.00211	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000285	0.00211	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GSTM1—glaucoma	0.000276	0.00204	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000274	0.00203	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NCK2—glaucoma	0.000274	0.00203	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—CDKN2B—glaucoma	0.000271	0.00201	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000271	0.00201	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—glaucoma	0.000268	0.00199	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000267	0.00198	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—CDKN2B—glaucoma	0.000266	0.00197	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000266	0.00197	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—NR3C1—glaucoma	0.00026	0.00193	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00026	0.00193	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000256	0.00189	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—CDKN2B—glaucoma	0.000255	0.00189	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—CDKN2B—glaucoma	0.000255	0.00189	CbGpPWpGaD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000252	0.00187	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—glaucoma	0.000252	0.00187	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000248	0.00184	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSTT1—glaucoma	0.000245	0.00181	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTT1—glaucoma	0.000245	0.00181	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.00024	0.00178	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NR3C1—glaucoma	0.000238	0.00176	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000236	0.00175	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—NR3C1—glaucoma	0.000233	0.00173	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000227	0.00169	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000225	0.00167	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NR3C1—glaucoma	0.000224	0.00166	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NR3C1—glaucoma	0.000224	0.00166	CbGpPWpGaD
Alitretinoin—Syncope—Clonidine—glaucoma	0.000222	0.000319	CcSEcCtD
Alitretinoin—Arrhythmia—Betaxolol—glaucoma	0.000221	0.000317	CcSEcCtD
Alitretinoin—Feeling abnormal—Dorzolamide—glaucoma	0.000221	0.000317	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00022	0.00163	CbGpPWpGaD
Alitretinoin—Decreased appetite—Pilocarpine—glaucoma	0.00022	0.000316	CcSEcCtD
Alitretinoin—Feeling abnormal—Travoprost—glaucoma	0.00022	0.000315	CcSEcCtD
Alitretinoin—Conjunctivitis—Timolol—glaucoma	0.000219	0.000314	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000219	0.000314	CcSEcCtD
Alitretinoin—Alopecia—Betaxolol—glaucoma	0.000219	0.000314	CcSEcCtD
Alitretinoin—Palpitations—Clonidine—glaucoma	0.000219	0.000314	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000219	0.000314	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Travoprost—glaucoma	0.000218	0.000313	CcSEcCtD
Alitretinoin—Loss of consciousness—Clonidine—glaucoma	0.000218	0.000312	CcSEcCtD
Alitretinoin—Feeling abnormal—Brinzolamide—glaucoma	0.000217	0.000311	CcSEcCtD
Alitretinoin—Mental disorder—Betaxolol—glaucoma	0.000217	0.000311	CcSEcCtD
Alitretinoin—Pain—Pilocarpine—glaucoma	0.000217	0.000311	CcSEcCtD
Alitretinoin—Constipation—Pilocarpine—glaucoma	0.000217	0.000311	CcSEcCtD
Alitretinoin—Cough—Clonidine—glaucoma	0.000216	0.00031	CcSEcCtD
Alitretinoin—Sweating—Timolol—glaucoma	0.000216	0.00031	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000216	0.0016	CbGpPWpGaD
Alitretinoin—Dizziness—Apraclonidine—glaucoma	0.000216	0.00031	CcSEcCtD
Alitretinoin—Malnutrition—Betaxolol—glaucoma	0.000216	0.000309	CcSEcCtD
Alitretinoin—Erythema—Betaxolol—glaucoma	0.000216	0.000309	CcSEcCtD
Alitretinoin—Urticaria—Dorzolamide—glaucoma	0.000213	0.000305	CcSEcCtD
Alitretinoin—Epistaxis—Timolol—glaucoma	0.000213	0.000305	CcSEcCtD
Alitretinoin—Abdominal pain—Dorzolamide—glaucoma	0.000212	0.000304	CcSEcCtD
Alitretinoin—Body temperature increased—Dorzolamide—glaucoma	0.000212	0.000304	CcSEcCtD
Alitretinoin—Tension—Betaxolol—glaucoma	0.000212	0.000304	CcSEcCtD
Alitretinoin—Sinusitis—Timolol—glaucoma	0.000212	0.000303	CcSEcCtD
Alitretinoin—Arthralgia—Clonidine—glaucoma	0.000211	0.000303	CcSEcCtD
Alitretinoin—Chest pain—Clonidine—glaucoma	0.000211	0.000303	CcSEcCtD
Alitretinoin—Abdominal pain—Travoprost—glaucoma	0.000211	0.000303	CcSEcCtD
Alitretinoin—Agranulocytosis—Timolol—glaucoma	0.00021	0.000302	CcSEcCtD
Alitretinoin—Anxiety—Clonidine—glaucoma	0.00021	0.000301	CcSEcCtD
Alitretinoin—Asthenia—Acetazolamide—glaucoma	0.00021	0.000301	CcSEcCtD
Alitretinoin—Dizziness—Bimatoprost—glaucoma	0.00021	0.000301	CcSEcCtD
Alitretinoin—Nervousness—Betaxolol—glaucoma	0.00021	0.0003	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000209	0.0003	CcSEcCtD
Alitretinoin—Urticaria—Brinzolamide—glaucoma	0.000209	0.0003	CcSEcCtD
Alitretinoin—Feeling abnormal—Pilocarpine—glaucoma	0.000209	0.000299	CcSEcCtD
Alitretinoin—Discomfort—Clonidine—glaucoma	0.000208	0.000299	CcSEcCtD
Alitretinoin—Vomiting—Apraclonidine—glaucoma	0.000208	0.000298	CcSEcCtD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000207	0.00154	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000207	0.000297	CcSEcCtD
Alitretinoin—Hypersensitivity—Brimonidine—glaucoma	0.000207	0.000297	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000207	0.00153	CbGpPWpGaD
Alitretinoin—Dry mouth—Clonidine—glaucoma	0.000206	0.000296	CcSEcCtD
Alitretinoin—Dermatitis—Apraclonidine—glaucoma	0.000206	0.000295	CcSEcCtD
Alitretinoin—Headache—Apraclonidine—glaucoma	0.000205	0.000294	CcSEcCtD
Alitretinoin—Confusional state—Clonidine—glaucoma	0.000204	0.000292	CcSEcCtD
Alitretinoin—Vision blurred—Betaxolol—glaucoma	0.000203	0.000292	CcSEcCtD
Alitretinoin—Oedema—Clonidine—glaucoma	0.000202	0.00029	CcSEcCtD
Alitretinoin—Tremor—Betaxolol—glaucoma	0.000202	0.00029	CcSEcCtD
Alitretinoin—Hallucination—Timolol—glaucoma	0.000201	0.000289	CcSEcCtD
Alitretinoin—Asthenia—Brimonidine—glaucoma	0.000201	0.000289	CcSEcCtD
Alitretinoin—Infection—Clonidine—glaucoma	0.000201	0.000288	CcSEcCtD
Alitretinoin—Abdominal pain—Pilocarpine—glaucoma	0.0002	0.000287	CcSEcCtD
Alitretinoin—Body temperature increased—Pilocarpine—glaucoma	0.0002	0.000287	CcSEcCtD
Alitretinoin—Ill-defined disorder—Betaxolol—glaucoma	0.0002	0.000287	CcSEcCtD
Alitretinoin—Diarrhoea—Acetazolamide—glaucoma	0.0002	0.000287	CcSEcCtD
Alitretinoin—Rash—Bimatoprost—glaucoma	0.0002	0.000287	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.0002	0.00148	CbGpPWpGaD
Alitretinoin—Dermatitis—Bimatoprost—glaucoma	0.0002	0.000286	CcSEcCtD
Alitretinoin—Oedema peripheral—Timolol—glaucoma	0.000199	0.000286	CcSEcCtD
Alitretinoin—Anaemia—Betaxolol—glaucoma	0.000199	0.000286	CcSEcCtD
Alitretinoin—Shock—Clonidine—glaucoma	0.000199	0.000285	CcSEcCtD
Alitretinoin—Pruritus—Brimonidine—glaucoma	0.000199	0.000285	CcSEcCtD
Alitretinoin—Headache—Bimatoprost—glaucoma	0.000199	0.000285	CcSEcCtD
Alitretinoin—Nervous system disorder—Clonidine—glaucoma	0.000198	0.000284	CcSEcCtD
Alitretinoin—Thrombocytopenia—Clonidine—glaucoma	0.000198	0.000284	CcSEcCtD
Alitretinoin—Hypersensitivity—Dorzolamide—glaucoma	0.000197	0.000283	CcSEcCtD
Alitretinoin—Tachycardia—Clonidine—glaucoma	0.000197	0.000283	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000197	0.00146	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000197	0.00146	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Travoprost—glaucoma	0.000197	0.000282	CcSEcCtD
Alitretinoin—Skin disorder—Clonidine—glaucoma	0.000196	0.000282	CcSEcCtD
Alitretinoin—Hyperhidrosis—Clonidine—glaucoma	0.000195	0.00028	CcSEcCtD
Alitretinoin—Visual impairment—Timolol—glaucoma	0.000195	0.00028	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—CYP1B1—glaucoma	0.000195	0.00144	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ABCA1—glaucoma	0.000195	0.00144	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCA1—glaucoma	0.000195	0.00144	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP1B1—glaucoma	0.000195	0.00144	CbGpPWpGaD
Alitretinoin—Malaise—Betaxolol—glaucoma	0.000195	0.000279	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000194	0.00144	CbGpPWpGaD
Alitretinoin—Nausea—Apraclonidine—glaucoma	0.000194	0.000278	CcSEcCtD
Alitretinoin—Hypersensitivity—Brinzolamide—glaucoma	0.000194	0.000278	CcSEcCtD
Alitretinoin—Syncope—Betaxolol—glaucoma	0.000193	0.000277	CcSEcCtD
Alitretinoin—Dizziness—Acetazolamide—glaucoma	0.000193	0.000277	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000193	0.00143	CbGpPWpGaD
Alitretinoin—Anorexia—Clonidine—glaucoma	0.000193	0.000276	CcSEcCtD
Alitretinoin—Asthenia—Dorzolamide—glaucoma	0.000192	0.000276	CcSEcCtD
Alitretinoin—Asthenia—Travoprost—glaucoma	0.000191	0.000275	CcSEcCtD
Alitretinoin—Palpitations—Betaxolol—glaucoma	0.000191	0.000273	CcSEcCtD
Alitretinoin—Pruritus—Dorzolamide—glaucoma	0.00019	0.000272	CcSEcCtD
Alitretinoin—Loss of consciousness—Betaxolol—glaucoma	0.00019	0.000272	CcSEcCtD
Alitretinoin—Eye disorder—Timolol—glaucoma	0.000189	0.000271	CcSEcCtD
Alitretinoin—Asthenia—Brinzolamide—glaucoma	0.000189	0.000271	CcSEcCtD
Alitretinoin—Hypotension—Clonidine—glaucoma	0.000189	0.000271	CcSEcCtD
Alitretinoin—Pruritus—Travoprost—glaucoma	0.000189	0.000271	CcSEcCtD
Alitretinoin—Tinnitus—Timolol—glaucoma	0.000189	0.000271	CcSEcCtD
Alitretinoin—Cough—Betaxolol—glaucoma	0.000188	0.00027	CcSEcCtD
Alitretinoin—Nausea—Bimatoprost—glaucoma	0.000188	0.00027	CcSEcCtD
Alitretinoin—Hypersensitivity—Pilocarpine—glaucoma	0.000187	0.000268	CcSEcCtD
Alitretinoin—Pruritus—Brinzolamide—glaucoma	0.000186	0.000267	CcSEcCtD
Alitretinoin—Vomiting—Acetazolamide—glaucoma	0.000186	0.000267	CcSEcCtD
Alitretinoin—Dizziness—Brimonidine—glaucoma	0.000186	0.000266	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000185	0.00137	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000184	0.000264	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—FAS—glaucoma	0.000184	0.00136	CbGpPWpGaD
Alitretinoin—Angiopathy—Timolol—glaucoma	0.000184	0.000263	CcSEcCtD
Alitretinoin—Myalgia—Betaxolol—glaucoma	0.000184	0.000263	CcSEcCtD
Alitretinoin—Arthralgia—Betaxolol—glaucoma	0.000184	0.000263	CcSEcCtD
Alitretinoin—Chest pain—Betaxolol—glaucoma	0.000184	0.000263	CcSEcCtD
Alitretinoin—Diarrhoea—Dorzolamide—glaucoma	0.000183	0.000263	CcSEcCtD
Alitretinoin—Headache—Acetazolamide—glaucoma	0.000183	0.000263	CcSEcCtD
Alitretinoin—Anxiety—Betaxolol—glaucoma	0.000183	0.000262	CcSEcCtD
Alitretinoin—Insomnia—Clonidine—glaucoma	0.000183	0.000262	CcSEcCtD
Alitretinoin—Diarrhoea—Travoprost—glaucoma	0.000183	0.000262	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000182	0.000262	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000182	0.00135	CbGpPWpGaD
Alitretinoin—Asthenia—Pilocarpine—glaucoma	0.000182	0.000261	CcSEcCtD
Alitretinoin—Paraesthesia—Clonidine—glaucoma	0.000182	0.00026	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—C3—glaucoma	0.000182	0.00135	CbGpPWpGaD
Alitretinoin—Discomfort—Betaxolol—glaucoma	0.000181	0.00026	CcSEcCtD
Alitretinoin—Arrhythmia—Timolol—glaucoma	0.000181	0.000259	CcSEcCtD
Alitretinoin—Dyspnoea—Clonidine—glaucoma	0.00018	0.000259	CcSEcCtD
Alitretinoin—Diarrhoea—Brinzolamide—glaucoma	0.00018	0.000259	CcSEcCtD
Alitretinoin—Somnolence—Clonidine—glaucoma	0.00018	0.000258	CcSEcCtD
Alitretinoin—Dry mouth—Betaxolol—glaucoma	0.00018	0.000258	CcSEcCtD
Alitretinoin—Pruritus—Pilocarpine—glaucoma	0.000179	0.000257	CcSEcCtD
Alitretinoin—Alopecia—Timolol—glaucoma	0.000179	0.000257	CcSEcCtD
Alitretinoin—Confusional state—Betaxolol—glaucoma	0.000178	0.000255	CcSEcCtD
Alitretinoin—Mental disorder—Timolol—glaucoma	0.000177	0.000254	CcSEcCtD
Alitretinoin—Dizziness—Dorzolamide—glaucoma	0.000177	0.000254	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—PAX6—glaucoma	0.000177	0.00131	CbGpPWpGaD
Alitretinoin—Rash—Brimonidine—glaucoma	0.000177	0.000254	CcSEcCtD
Alitretinoin—Dermatitis—Brimonidine—glaucoma	0.000177	0.000254	CcSEcCtD
Alitretinoin—Dizziness—Travoprost—glaucoma	0.000176	0.000253	CcSEcCtD
Alitretinoin—Erythema—Timolol—glaucoma	0.000176	0.000253	CcSEcCtD
Alitretinoin—Malnutrition—Timolol—glaucoma	0.000176	0.000253	CcSEcCtD
Alitretinoin—Oedema—Betaxolol—glaucoma	0.000176	0.000252	CcSEcCtD
Alitretinoin—Headache—Brimonidine—glaucoma	0.000176	0.000252	CcSEcCtD
Alitretinoin—Decreased appetite—Clonidine—glaucoma	0.000176	0.000252	CcSEcCtD
Alitretinoin—Infection—Betaxolol—glaucoma	0.000175	0.000251	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Clonidine—glaucoma	0.000175	0.00025	CcSEcCtD
Alitretinoin—Fatigue—Clonidine—glaucoma	0.000174	0.00025	CcSEcCtD
Alitretinoin—Dizziness—Brinzolamide—glaucoma	0.000174	0.00025	CcSEcCtD
Alitretinoin—Nausea—Acetazolamide—glaucoma	0.000174	0.000249	CcSEcCtD
Alitretinoin—Diarrhoea—Pilocarpine—glaucoma	0.000173	0.000248	CcSEcCtD
Alitretinoin—Shock—Betaxolol—glaucoma	0.000173	0.000248	CcSEcCtD
Alitretinoin—Tension—Timolol—glaucoma	0.000173	0.000248	CcSEcCtD
Alitretinoin—Pain—Clonidine—glaucoma	0.000173	0.000248	CcSEcCtD
Alitretinoin—Constipation—Clonidine—glaucoma	0.000173	0.000248	CcSEcCtD
Alitretinoin—Nervous system disorder—Betaxolol—glaucoma	0.000173	0.000248	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betaxolol—glaucoma	0.000172	0.000247	CcSEcCtD
Alitretinoin—Tachycardia—Betaxolol—glaucoma	0.000172	0.000246	CcSEcCtD
Alitretinoin—Nervousness—Timolol—glaucoma	0.000171	0.000245	CcSEcCtD
Alitretinoin—Skin disorder—Betaxolol—glaucoma	0.000171	0.000245	CcSEcCtD
Alitretinoin—Vomiting—Dorzolamide—glaucoma	0.00017	0.000244	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.00017	0.00126	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Betaxolol—glaucoma	0.00017	0.000244	CcSEcCtD
Alitretinoin—Rash—Dorzolamide—glaucoma	0.000169	0.000242	CcSEcCtD
Alitretinoin—Dermatitis—Dorzolamide—glaucoma	0.000169	0.000242	CcSEcCtD
Alitretinoin—Rash—Travoprost—glaucoma	0.000168	0.000241	CcSEcCtD
Alitretinoin—Dermatitis—Travoprost—glaucoma	0.000168	0.000241	CcSEcCtD
Alitretinoin—Headache—Dorzolamide—glaucoma	0.000168	0.000241	CcSEcCtD
Alitretinoin—Anorexia—Betaxolol—glaucoma	0.000168	0.000241	CcSEcCtD
Alitretinoin—Vomiting—Brinzolamide—glaucoma	0.000168	0.00024	CcSEcCtD
Alitretinoin—Dizziness—Pilocarpine—glaucoma	0.000167	0.00024	CcSEcCtD
Alitretinoin—Headache—Travoprost—glaucoma	0.000167	0.00024	CcSEcCtD
Alitretinoin—Nausea—Brimonidine—glaucoma	0.000167	0.000239	CcSEcCtD
Alitretinoin—Feeling abnormal—Clonidine—glaucoma	0.000167	0.000239	CcSEcCtD
Alitretinoin—Rash—Brinzolamide—glaucoma	0.000166	0.000238	CcSEcCtD
Alitretinoin—Vision blurred—Timolol—glaucoma	0.000166	0.000238	CcSEcCtD
Alitretinoin—Dermatitis—Brinzolamide—glaucoma	0.000166	0.000238	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Clonidine—glaucoma	0.000165	0.000237	CcSEcCtD
Alitretinoin—Headache—Brinzolamide—glaucoma	0.000165	0.000237	CcSEcCtD
Alitretinoin—Hypotension—Betaxolol—glaucoma	0.000165	0.000236	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000163	0.00121	CbGpPWpGaD
Alitretinoin—Vomiting—Pilocarpine—glaucoma	0.000161	0.000231	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000161	0.00119	CbGpPWpGaD
Alitretinoin—Urticaria—Clonidine—glaucoma	0.000161	0.00023	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00016	0.00023	CcSEcCtD
Alitretinoin—Abdominal pain—Clonidine—glaucoma	0.00016	0.000229	CcSEcCtD
Alitretinoin—Body temperature increased—Clonidine—glaucoma	0.00016	0.000229	CcSEcCtD
Alitretinoin—Rash—Pilocarpine—glaucoma	0.00016	0.000229	CcSEcCtD
Alitretinoin—Dermatitis—Pilocarpine—glaucoma	0.00016	0.000229	CcSEcCtD
Alitretinoin—Insomnia—Betaxolol—glaucoma	0.000159	0.000228	CcSEcCtD
Alitretinoin—Nausea—Dorzolamide—glaucoma	0.000159	0.000228	CcSEcCtD
Alitretinoin—Headache—Pilocarpine—glaucoma	0.000159	0.000228	CcSEcCtD
Alitretinoin—Nausea—Travoprost—glaucoma	0.000158	0.000227	CcSEcCtD
Alitretinoin—Paraesthesia—Betaxolol—glaucoma	0.000158	0.000227	CcSEcCtD
Alitretinoin—Syncope—Timolol—glaucoma	0.000158	0.000227	CcSEcCtD
Alitretinoin—Dyspnoea—Betaxolol—glaucoma	0.000157	0.000225	CcSEcCtD
Alitretinoin—Nausea—Brinzolamide—glaucoma	0.000156	0.000224	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—GSTM1—glaucoma	0.000156	0.00115	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTM1—glaucoma	0.000156	0.00115	CbGpPWpGaD
Alitretinoin—Palpitations—Timolol—glaucoma	0.000156	0.000223	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000156	0.00115	CbGpPWpGaD
Alitretinoin—Dyspepsia—Betaxolol—glaucoma	0.000155	0.000222	CcSEcCtD
Alitretinoin—Loss of consciousness—Timolol—glaucoma	0.000155	0.000222	CcSEcCtD
Alitretinoin—Cough—Timolol—glaucoma	0.000154	0.000221	CcSEcCtD
Alitretinoin—Decreased appetite—Betaxolol—glaucoma	0.000153	0.000219	CcSEcCtD
Alitretinoin—Hypertension—Timolol—glaucoma	0.000152	0.000218	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000152	0.000218	CcSEcCtD
Alitretinoin—Fatigue—Betaxolol—glaucoma	0.000152	0.000218	CcSEcCtD
Alitretinoin—Pain—Betaxolol—glaucoma	0.000151	0.000216	CcSEcCtD
Alitretinoin—Constipation—Betaxolol—glaucoma	0.000151	0.000216	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.00015	0.00111	CbGpPWpGaD
Alitretinoin—Nausea—Pilocarpine—glaucoma	0.00015	0.000216	CcSEcCtD
Alitretinoin—Myalgia—Timolol—glaucoma	0.00015	0.000215	CcSEcCtD
Alitretinoin—Chest pain—Timolol—glaucoma	0.00015	0.000215	CcSEcCtD
Alitretinoin—Arthralgia—Timolol—glaucoma	0.00015	0.000215	CcSEcCtD
Alitretinoin—Anxiety—Timolol—glaucoma	0.00015	0.000214	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000149	0.000214	CcSEcCtD
Alitretinoin—Hypersensitivity—Clonidine—glaucoma	0.000149	0.000214	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000149	0.0011	CbGpPWpGaD
Alitretinoin—Discomfort—Timolol—glaucoma	0.000148	0.000213	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CA1—glaucoma	0.000148	0.0011	CbGpPWpGaD
Alitretinoin—Dry mouth—Timolol—glaucoma	0.000147	0.00021	CcSEcCtD
Alitretinoin—Asthenia—Clonidine—glaucoma	0.000145	0.000208	CcSEcCtD
Alitretinoin—Feeling abnormal—Betaxolol—glaucoma	0.000145	0.000208	CcSEcCtD
Alitretinoin—Confusional state—Timolol—glaucoma	0.000145	0.000208	CcSEcCtD
Alitretinoin—Oedema—Timolol—glaucoma	0.000144	0.000206	CcSEcCtD
Alitretinoin—Anaphylactic shock—Timolol—glaucoma	0.000144	0.000206	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CTSA—glaucoma	0.000144	0.00106	CbGpPWpGaD
Alitretinoin—Pruritus—Clonidine—glaucoma	0.000143	0.000205	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000143	0.00106	CbGpPWpGaD
Alitretinoin—Infection—Timolol—glaucoma	0.000143	0.000205	CcSEcCtD
Alitretinoin—RARG—Gene Expression—CDKN2B—glaucoma	0.000143	0.00106	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000142	0.00106	CbGpPWpGaD
Alitretinoin—Shock—Timolol—glaucoma	0.000141	0.000203	CcSEcCtD
Alitretinoin—Nervous system disorder—Timolol—glaucoma	0.000141	0.000202	CcSEcCtD
Alitretinoin—Urticaria—Betaxolol—glaucoma	0.00014	0.000201	CcSEcCtD
Alitretinoin—Skin disorder—Timolol—glaucoma	0.00014	0.0002	CcSEcCtD
Alitretinoin—Body temperature increased—Betaxolol—glaucoma	0.000139	0.0002	CcSEcCtD
Alitretinoin—Hyperhidrosis—Timolol—glaucoma	0.000139	0.000199	CcSEcCtD
Alitretinoin—Diarrhoea—Clonidine—glaucoma	0.000138	0.000198	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000138	0.00102	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—MTHFR—glaucoma	0.000138	0.00102	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—MTHFR—glaucoma	0.000138	0.00102	CbGpPWpGaD
Alitretinoin—Anorexia—Timolol—glaucoma	0.000137	0.000197	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CA2—glaucoma	0.000136	0.001	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000135	0.001	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000135	0.001	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000135	0.001	CbGpPWpGaD
Alitretinoin—Hypotension—Timolol—glaucoma	0.000134	0.000193	CcSEcCtD
Alitretinoin—Dizziness—Clonidine—glaucoma	0.000134	0.000192	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000133	0.000988	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—CDKN2B—glaucoma	0.000133	0.000985	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000132	0.000982	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000132	0.000982	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—glaucoma	0.000131	0.000973	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Timolol—glaucoma	0.000131	0.000188	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—CDKN2B—glaucoma	0.000131	0.000967	CbGpPWpGaD
Alitretinoin—Insomnia—Timolol—glaucoma	0.00013	0.000187	CcSEcCtD
Alitretinoin—Hypersensitivity—Betaxolol—glaucoma	0.00013	0.000186	CcSEcCtD
Alitretinoin—Paraesthesia—Timolol—glaucoma	0.000129	0.000185	CcSEcCtD
Alitretinoin—Vomiting—Clonidine—glaucoma	0.000129	0.000184	CcSEcCtD
Alitretinoin—Dyspnoea—Timolol—glaucoma	0.000128	0.000184	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—APOE—glaucoma	0.000128	0.00095	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—APOE—glaucoma	0.000128	0.00095	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—CDKN2B—glaucoma	0.000128	0.000949	CbGpPWpGaD
Alitretinoin—Somnolence—Timolol—glaucoma	0.000128	0.000183	CcSEcCtD
Alitretinoin—Rash—Clonidine—glaucoma	0.000127	0.000183	CcSEcCtD
Alitretinoin—Dermatitis—Clonidine—glaucoma	0.000127	0.000183	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—CAV1—glaucoma	0.000127	0.000942	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CAV1—glaucoma	0.000127	0.000942	CbGpPWpGaD
Alitretinoin—Headache—Clonidine—glaucoma	0.000127	0.000182	CcSEcCtD
Alitretinoin—Dyspepsia—Timolol—glaucoma	0.000127	0.000182	CcSEcCtD
Alitretinoin—Asthenia—Betaxolol—glaucoma	0.000126	0.000181	CcSEcCtD
Alitretinoin—RARG—Gene Expression—NR3C1—glaucoma	0.000125	0.000928	CbGpPWpGaD
Alitretinoin—Decreased appetite—Timolol—glaucoma	0.000125	0.000179	CcSEcCtD
Alitretinoin—Pruritus—Betaxolol—glaucoma	0.000125	0.000179	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Timolol—glaucoma	0.000124	0.000178	CcSEcCtD
Alitretinoin—Fatigue—Timolol—glaucoma	0.000124	0.000178	CcSEcCtD
Alitretinoin—Pain—Timolol—glaucoma	0.000123	0.000176	CcSEcCtD
Alitretinoin—RARA—Gene Expression—CDKN2B—glaucoma	0.000123	0.00091	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—CDKN2B—glaucoma	0.000123	0.00091	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA5A—glaucoma	0.000121	0.000899	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NARFL—glaucoma	0.000121	0.000899	CbGpPWpGaD
Alitretinoin—Diarrhoea—Betaxolol—glaucoma	0.00012	0.000173	CcSEcCtD
Alitretinoin—Nausea—Clonidine—glaucoma	0.00012	0.000172	CcSEcCtD
Alitretinoin—Feeling abnormal—Timolol—glaucoma	0.000119	0.00017	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Timolol—glaucoma	0.000118	0.000169	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—NR3C1—glaucoma	0.000117	0.000864	CbGpPWpGaD
Alitretinoin—Dizziness—Betaxolol—glaucoma	0.000116	0.000167	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000116	0.00086	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR3C1—glaucoma	0.000115	0.000849	CbGpPWpGaD
Alitretinoin—Urticaria—Timolol—glaucoma	0.000114	0.000164	CcSEcCtD
Alitretinoin—Abdominal pain—Timolol—glaucoma	0.000114	0.000163	CcSEcCtD
Alitretinoin—Body temperature increased—Timolol—glaucoma	0.000114	0.000163	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000113	0.000835	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NR3C1—glaucoma	0.000112	0.000833	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000112	0.000832	CbGpPWpGaD
Alitretinoin—Vomiting—Betaxolol—glaucoma	0.000112	0.000161	CcSEcCtD
Alitretinoin—Rash—Betaxolol—glaucoma	0.000111	0.000159	CcSEcCtD
Alitretinoin—Dermatitis—Betaxolol—glaucoma	0.000111	0.000159	CcSEcCtD
Alitretinoin—Headache—Betaxolol—glaucoma	0.00011	0.000158	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.00011	0.000816	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000109	0.000805	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR3C1—glaucoma	0.000108	0.000798	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR3C1—glaucoma	0.000108	0.000798	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000107	0.000792	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000106	0.000787	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Timolol—glaucoma	0.000106	0.000152	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000105	0.000781	CbGpPWpGaD
Alitretinoin—Nausea—Betaxolol—glaucoma	0.000105	0.00015	CcSEcCtD
Alitretinoin—Asthenia—Timolol—glaucoma	0.000103	0.000148	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000103	0.000762	CbGpPWpGaD
Alitretinoin—Pruritus—Timolol—glaucoma	0.000102	0.000146	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.92e-05	0.000736	CbGpPWpGaD
Alitretinoin—Diarrhoea—Timolol—glaucoma	9.84e-05	0.000141	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism—CA5A—glaucoma	9.68e-05	0.000718	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NARFL—glaucoma	9.68e-05	0.000718	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	9.65e-05	0.000716	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	9.62e-05	0.000713	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	9.62e-05	0.000713	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NOS3—glaucoma	9.61e-05	0.000712	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NOS3—glaucoma	9.61e-05	0.000712	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TXN—glaucoma	9.55e-05	0.000708	CbGpPWpGaD
Alitretinoin—Dizziness—Timolol—glaucoma	9.51e-05	0.000136	CcSEcCtD
Alitretinoin—Vomiting—Timolol—glaucoma	9.14e-05	0.000131	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—glaucoma	9.12e-05	0.000676	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.09e-05	0.000674	CbGpPWpGaD
Alitretinoin—Rash—Timolol—glaucoma	9.07e-05	0.00013	CcSEcCtD
Alitretinoin—Dermatitis—Timolol—glaucoma	9.06e-05	0.00013	CcSEcCtD
Alitretinoin—Headache—Timolol—glaucoma	9.01e-05	0.000129	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—glaucoma	8.8e-05	0.000652	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—glaucoma	8.78e-05	0.000651	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—glaucoma	8.78e-05	0.000651	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.71e-05	0.000646	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	8.68e-05	0.000643	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.63e-05	0.00064	CbGpPWpGaD
Alitretinoin—Nausea—Timolol—glaucoma	8.54e-05	0.000123	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.51e-05	0.000631	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—glaucoma	7.82e-05	0.000579	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—glaucoma	7.8e-05	0.000578	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	7.77e-05	0.000576	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—glaucoma	7.41e-05	0.000549	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.26e-05	0.000538	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CDKN2B—glaucoma	6.4e-05	0.000474	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.97e-05	0.000443	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA1—glaucoma	5.92e-05	0.000439	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1B1—glaucoma	5.9e-05	0.000437	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCA1—glaucoma	5.9e-05	0.000437	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—glaucoma	5.87e-05	0.000435	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CTSA—glaucoma	5.74e-05	0.000425	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.71e-05	0.000424	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR3C1—glaucoma	5.61e-05	0.000416	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA2—glaucoma	5.42e-05	0.000402	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.41e-05	0.000401	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—glaucoma	5.27e-05	0.00039	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA1—glaucoma	4.73e-05	0.00035	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—glaucoma	4.72e-05	0.00035	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CTSA—glaucoma	4.58e-05	0.000339	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—glaucoma	4.51e-05	0.000335	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.5e-05	0.000334	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA2—glaucoma	4.32e-05	0.000321	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.23e-05	0.000313	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.23e-05	0.000313	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—glaucoma	4.17e-05	0.000309	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—glaucoma	3.88e-05	0.000288	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.86e-05	0.000286	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAV1—glaucoma	3.85e-05	0.000285	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TXN—glaucoma	3.82e-05	0.000283	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.4e-05	0.000252	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TXN—glaucoma	3.05e-05	0.000226	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—glaucoma	2.96e-05	0.000219	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—glaucoma	2.91e-05	0.000216	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.78e-05	0.000206	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.75e-05	0.000204	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—glaucoma	2.66e-05	0.000197	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—glaucoma	2.36e-05	0.000175	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCA1—glaucoma	2.36e-05	0.000175	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1B1—glaucoma	2.36e-05	0.000175	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.91e-05	0.000141	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—glaucoma	1.89e-05	0.00014	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCA1—glaucoma	1.88e-05	0.00014	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1B1—glaucoma	1.88e-05	0.00014	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—glaucoma	1.67e-05	0.000123	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—glaucoma	1.55e-05	0.000115	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAV1—glaucoma	1.54e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—glaucoma	1.5e-05	0.000112	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—glaucoma	1.33e-05	9.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—glaucoma	1.24e-05	9.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAV1—glaucoma	1.23e-05	9.09e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—glaucoma	1.16e-05	8.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—glaucoma	1.06e-05	7.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—glaucoma	9.28e-06	6.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—glaucoma	8.48e-06	6.29e-05	CbGpPWpGaD
